Apply on Employer Site

Toragen, Inc. · 1 day ago

Scientist I

San Diego, CA

Full-time

Onsite

Mid Level

3+ years exp

Toragen, Inc. is a clinical-stage oncology company focused on the treatment of HPV-induced cancers. They are seeking a highly motivated Scientist to join their drug discovery team, responsible for designing and executing in vitro studies related to immuno-oncology and virology.

Biotechnology

Hiring Manager

Whitney Bullard, Ph.D.

Responsibilities

Design, execute, and interpret in vitro experiments to characterize compound activity and investigate biological mechanisms of action

Perform hands-on cell and molecular biology experiments, including flow cytometry, cell proliferation and viability assays, Western blotting, qPCR, and ELISA., and flow cytometry

Develop, optimize, and troubleshoot biochemical and cell-based assays to evaluate small-molecule compounds

Analyze and synthesize experimental data to guide discovery and translational research strategies

Present experimental results and project updates at internal team meetings and contribute to cross-functional discussions

Qualification

CellMolecular biologyAssay developmentCancer biologyImmuno-oncologyTranslational researchBiochemical assaysCommunicationTeam collaborationAdaptabilityMotivation

Required

PhD in biochemistry, cell biology, cancer biology, pharmacology, or a related discipline with 2–80-2 years of relevant academic and/or industry experienceindustry or postdoctoral experience; or MS with 7+ years.3-6 years industry or equivalent research experience

Strong background in cell and molecular biology, including mammalian cell culture and assay development

Demonstrated ability to independently design experiments, analyze data, and draw biologically meaningful conclusions

Excellent communication skills and the ability to work effectively in a collaborative, interdisciplinary team environment

Highly motivated, adaptable, and eager to learn new technologies while contributing across multiple projects

Preferred

Experience with cancer biologyimmuno-oncology, translational research, or and biomarker development is highly desirable

Company

Toragen, Inc.

Toragen is focused on developing novel immunotherapies to treat viral-associated cancers.

Founded in 2016

San Diego, California, USA

2-10 employees

https://toragen.com

Funding

Current Stage

Early Stage

Total Funding

$17.4M

Key Investors

Bill & Melinda Gates FoundationScott Rasgon,Steven LebowPaul Engler

2025-10-29Grant

2025-09-30Debt Financing· $12M

2022-09-30Seed· $5.4M

Leadership Team

Cheryl Collett, CPA

Chief Financial Officer

Neil Clendeninn

Chief Medical Officer

Recent News

Business Wire

Toragen, Inc., Receives Grant to Conduct Studies to Explore Application of TGN-S15 for Premalignant Lesions at Earliest Stages

2025-10-30

Morningstar.com

Toragen, Inc. Announces $12 Million Convertible Note Financing and Expansion of Board of Directors

2025-10-01

Google Patent

2-s rimantadine and 2-r rimantadine for treating cancer and precancerous …

2025-05-04

Company data provided by crunchbase